Texas A&M University

Stories

FDA clears personalized magnetic brain therapy for PTSD after trial reports high remission

Ran the MeRT clinical trial and publicized results

The Food and Drug Administration cleared a personalized magnetic brain therapy for PTSD in June 2026. The maker's trial reports a 68% remission rate, more than four times the maximum seen in a 2020 review of standard PTSD medications.

Updated 3 hours ago

Scientists find a cellular target for coffee's link to healthy aging

New Capabilities

Institution behind the study

For decades, studies have linked coffee drinkers to lower rates of several age-related diseases. Nobody could say why. A Texas A&M lab now names a plausible reason: coffee compounds latch onto a cell receptor called NR4A1.

Updated Jul 19